Corporate development

Matthews International Announces Second Quarter Fiscal 2024 Earnings Release and Conference Call

Retrieved on:

Monday, April 8, 2024

PITTSBURGH, April 08, 2024 (GLOBE NEWSWIRE) -- Matthews International Corporation (Nasdaq GSM: MATW) today announced plans to release its second quarter fiscal year 2024 earnings results after the market closes on Thursday, May 2, 2024.

Key Points:

PITTSBURGH, April 08, 2024 (GLOBE NEWSWIRE) -- Matthews International Corporation (Nasdaq GSM: MATW) today announced plans to release its second quarter fiscal year 2024 earnings results after the market closes on Thursday, May 2, 2024.
The Company will host a conference call and webcast to review the financial and operating results for the period and discuss its outlook.
Participating in the call will be Joseph C. Bartolacci, President and CEO, Steven F. Nicola, Chief Financial Officer, and William D. Wilson, Senior Director, Corporate Development.
A question-and-answer session will follow.

Theratechnologies Appoints Elina Tea to its Board of Directors

Retrieved on:

Friday, April 5, 2024

Corporation, SNC-Lavalin, McGill University, Chair, Desjardins Group, Office of the President, Commerce, TSX, GLS, M&A, Corporate development, RBC Capital Markets, Management

Tea will be Investissement Québec’s designee pursuant to its investor rights agreement with the Company.

Key Points:

Tea will be Investissement Québec’s designee pursuant to its investor rights agreement with the Company.
“Elina Tea’s extensive experience in finance, corporate strategy, and investor relations makes her a valuable addition to our Board of Directors,” said Dawn Svoronos, Chair of the Board of Directors at Theratechnologies.
She brings a welcomed perspective to Theratechnologies as the Company focuses on its commercial business and the search for new products and partners.”
“It’s an honor to join the distinguished Board of Directors of Theratechnologies and I look forward to contributing to the Company’s path to success and value creation,” said Elina Tea.
With the appointment of Elina Tea, the Company’s Audit Committee will now comprise four independent members including the recently appointed Jordan Zwick, Gerald Lacoste, and Frank Holler as Chair.

Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

Retrieved on:

Friday, April 5, 2024

DJO, KPMG, Foot, Sale, Controller, Senior, SMTI, History, BSN, Planet, Orthopedic surgery, Marketing, Corporate development

Zach Fleming, Sanara's Chief Executive Officer, stated, “Jake and Tyler are seasoned executives with a wealth of experience in the medical device and wound care industries.

Key Points:

Zach Fleming, Sanara's Chief Executive Officer, stated, “Jake and Tyler are seasoned executives with a wealth of experience in the medical device and wound care industries.
Mr. Palmer brings extensive expertise in the healthcare sector, particularly in leading strategic growth and corporate development initiatives aimed at enhancing financial and clinical outcomes for providers, while maximizing shareholder returns.
In his most recent role, Mr. Palmer served as the Senior Vice President of Corporate Development, Strategy, and Product at AQuity Solutions, a leading provider of outsourced revenue cycle and clinical documentation solutions.
Under his leadership, he crafted and executed a strategic vision that included multiple successful acquisitions and technology investments.

Trisura Group Announces Changes to its Board of Directors

Retrieved on:

Thursday, April 4, 2024

Risk management, General counsel, Intact Financial, Power Corporation of Canada, TSX, Annual general meeting, Investment, Retirement, Corporate development, Corporation

TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU) today announced the appointment of Lilia Sham to its Board of Directors and the retirement of Greg Morrison.

Key Points:

TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Trisura Group Ltd. (“Trisura” or “Trisura Group”) (TSX: TSU) today announced the appointment of Lilia Sham to its Board of Directors and the retirement of Greg Morrison.
In addition, Trisura today announced that Sacha Haque is expected to stand for election to the Board of Directors at this year’s Annual General Meeting.
“We are pleased to welcome Lilia Sham to our Board of Directors and look forward to the expected election of Sacha Haque to our Board of Directors at our Annual General Meeting on June 3, 2024.
We look forward to the guidance Ms. Sham and Ms. Haque will provide as Trisura continues to execute its strategy.” said George Myhal, Chair, Board of Directors, Trisura Group Ltd.
Mr. Myhal continued, “We would also like to thank Greg Morrison for his many contributions to Trisura.

Cape Fox Corporation Welcomes Senior Vice President of Construction Services

Retrieved on:

Thursday, April 4, 2024

Bristol Bay Native Corporation, University, Cape, PPS, Knowledge, Integration, CFC, Senior, FCG, Marketing, Corporate development, BBCH, Management

Chantilly, Virginia, United States, April 04, 2024 (GLOBE NEWSWIRE) -- Cape Fox Corporation (CFC) is pleased to announce that Jason Brown has joined the Cape Fox Team as the Senior Vice President of Construction Services.

Key Points:

Chantilly, Virginia, United States, April 04, 2024 (GLOBE NEWSWIRE) -- Cape Fox Corporation (CFC) is pleased to announce that Jason Brown has joined the Cape Fox Team as the Senior Vice President of Construction Services.
CFC looks forward to working closely with Jason as we expand and grow our construction and engineering services as an industry leader.
As the Senior Vice President of Construction Services, he will develop and grow our construction team and business lines for CFC.
With his extensive industry experience, he and his team will champion the Cape Fox Federal Contracting Group (FCG) mission of providing high-quality services, value-driven solutions, and specialized construction services that address all aspects of the design-to-build lifecycle.

Ninepoint Partners Appoints Christopher Bean as Head of Corporate Development

Retrieved on:

Wednesday, April 3, 2024

Stikeman Elliott, Bean, Growth, LLP, University, RBC, Investment, MBA, Corporate development, RBC Capital Markets, Management

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint”), one of Canada’s leading alternative investment management firms, announced the appointment of Christopher Bean as Managing Director, Head of Corporate Development.

Key Points:

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Ninepoint Partners LP (“Ninepoint”), one of Canada’s leading alternative investment management firms, announced the appointment of Christopher Bean as Managing Director, Head of Corporate Development.
In this role, he will be responsible for identifying, evaluating, and executing strategic initiatives to drive growth of the organization.
Bean has more than two decades of experience as an investment banker, strategic advisor and corporate lawyer.
Bean holds an MBA from INSEAD and a Bachelor of Laws from the University of Western Ontario.

Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development

Retrieved on:

Wednesday, April 3, 2024

Growth, Goldman Sachs, Customer, Mathematical sciences, Harvard Business School, Head, Mathematics, MSIM, Corporate development

WARREN, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc (‘Tevogen Bio’) (Nasdaq: TVGN), a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of Investor Relations and Corporate Development. Mr. Shah, a Wall Street veteran with over 25 years of experience across key financial services industry verticals, brings broad leadership capabilities to Tevogen Bio.

Key Points:

WARREN, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc (‘Tevogen Bio’) (Nasdaq: TVGN ), a clinical-stage biotech company, announces the appointment of Tapan V Shah as Head of Investor Relations and Corporate Development.
Mr. Shah, a Wall Street veteran with over 25 years of experience across key financial services industry verticals, brings broad leadership capabilities to Tevogen Bio.
Most recently, Mr. Shah was Director, Relationship Management, in Citigroup’s Client organization, where he was also a member of the Executive Office.
Prior to Citigroup, he worked in Morgan Stanley’s asset management business (MSIM) focused on Equity Strategy and Product Development.

Avalo Therapeutics Appoints Biotech Leaders to Board of Directors

Retrieved on:

Tuesday, April 2, 2024

The Avalo Board brings together a team with expertise spanning finance, business operations, drug discovery and clinical development.

Key Points:

The Avalo Board brings together a team with expertise spanning finance, business operations, drug discovery and clinical development.
The recent board appointments include Aaron Kantoff, Jonathan Goldman, and Samantha Truex as Independent Directors.
He has spent over a decade specializing in founding, building and investing in biotech companies.
Samantha also chairs the Board of Advisors for Thayer School of Engineering at Dartmouth and is a member of the Board of Advisors for Life Science Cares.

United Lithium Announces Results from the 2024 Annual General and Special Meeting of Shareholders

Retrieved on:

Monday, April 1, 2024

Lithium, Remuneration, Proxy, Meeting, Corporate development, Security (finance)

At the Meeting, the shareholders of the Company also approved:

Key Points:

At the Meeting, the shareholders of the Company also approved:
the re-appointment of Dale Matheson Carr-Hilton LaBonte LLP as the auditor of the Company for the ensuing year and authorized the directors to fix their remuneration; and
the Company’s new Compensation Plan.
The total number of common shares of United Lithium represented by shareholders in person or by proxy at the Meeting was 5,771,433 common shares, representing 14.05% of the total issued and outstanding common shares at the record date for the Meeting.
The Company also announces the departure of Anoop Prihar, Vice President, Corporate Development.
The board of directors thank Mr. Prihar for his service and wish him success in all his future endeavors.

Ardelyx, Inc. Reports Employment Inducement Grants

Retrieved on:

Thursday, March 28, 2024

Indian stock exchange, Employment, Corporate development, RSU

The stock option granted to Mr. Kelliher and each stock option granted to the non-executive employees has an exercise price equal to $7.70 per share, which was the closing trading price of the company’s common stock on the date of grant.

Key Points:

The stock option granted to Mr. Kelliher and each stock option granted to the non-executive employees has an exercise price equal to $7.70 per share, which was the closing trading price of the company’s common stock on the date of grant.
The stock options and RSUs granted to Mr. Kelliher and all non-executive employees were granted as inducements material to each employee’s decision to enter into employment with Ardelyx, in accordance with Nasdaq Listing Rule 5635(c)(4).
The stock option granted to Mr. Kelliher and each stock option granted to the non-executive employees vest over four years, with 25% of the shares vesting on the first anniversary of the employee’s first date of employment, and the remaining 75% of shares vesting monthly thereafter.
Each stock option has a 10-year term and each option and RSU is subject to the terms and conditions of the company’s 2016 Employment Commencement Incentive Plan and the award agreement covering the grant.